QuidelOrtho
Blood typing and factor determination (Ortho Clinical Diagnostics).
Inter Pharm is the authorised distributor of QuidelOrtho (US) in Montenegro. Distribution covers public and private clinical accounts — the Clinical Centre of Montenegro and every regional general hospital — under CInMED wholesale licence number 2050/22/482/2-6492, within an ISO 9001:2015 quality-management and ISO 14001:2015 environmental-management system.
- Status
- Authorised distributor
- Country of origin
- US
- Manufacturer
- quidelortho.com
Specialties
Clinical application
Distribution
Inter Pharm — authorised distributor of QuidelOrtho
We distribute QuidelOrtho in Montenegro under a CInMED licence for wholesale of medicines and medical devices, within an ISO 9001 quality-management system and an ISO 14001 environmental-management system.
Credentials
- ISO 9001:201524-A-2817 Rev.0IAFCertSearch →
- ISO 14001:201524-C-1576 Rev.0IAFCertSearch →
- CInMED licence2050/22/482/2-6492
About the manufacturer
QuidelOrtho — origin and portfolio
QuidelOrtho is a US manufacturer of in-vitro diagnostics formed in 2022 by the merger of Quidel Corporation and Ortho Clinical Diagnostics. The portfolio covers blood typing, transfusion diagnostics, infectious-disease assays, rapid testing, and automated immunohaematology platforms. ID-MTS gel cards for blood typing are a reference standard in transfusion laboratories.
- Headquarters
- San Diego, California, USA
- Primary product lines
- ID-MTS gel cards · ORTHO Vision automated platform · ORTHO Optix reader · Vitros 5,1 · Vitros XT 7600
Technology
What sets QuidelOrtho apart
QuidelOrtho manufactures instruments and reagents for immunohaematology, clinical chemistry, and immunoassay testing. The ID-MTS gel card line uses column agglutination technology for blood typing and compatibility testing. The VITROS family covers chemistry and immunoassay using dry-slide technology.
Clinical applications
Where it is used in routine practice
- ABO and RhD blood grouping of patients and donors
- Antibody screening and identification
- Direct and indirect antiglobulin (Coombs) testing
- Pre-transfusion crossmatching
- Clinical chemistry on dry-slide technology
- Immunoassay for cardiac, infectious, and hormone markers
Portfolio
Product lines in detail
- ID-MTS gel kartice
- Gel cards using column agglutination for blood typing, antibody testing, and compatibility.
- ORTHO VISION
- Automated immunohaematology analyser for routine patient and donor testing in transfusion services.
- ORTHO VISION Swift
- ORTHO Vision platform variant with increased processing power and data security.
- ORTHO Workstation
- Semi-automated immunohaematology solution built around ID-MTS gel cards.
- ORTHO OPTIX Reader
- Gel card reader that completes the semi-automated workflow in transfusion laboratories.
- VITROS XT serija
- Clinical chemistry analysers using dry-slide technology for routine biochemistry panels.
- VITROS imunoanalitički analizatori
- Immunoassay analysers for cardiac, hormone, and infectious disease markers.
Distribution in Montenegro
Inter Pharm role
Inter Pharm distributes QuidelOrtho in Montenegro for public-sector transfusion laboratories. All supply runs under CInMED licence 2050/22/482/2-6492 within an ISO 9001:2015 system.
FAQ
Frequently asked questions: QuidelOrtho
- Is Inter Pharm the authorised distributor of QuidelOrtho in Montenegro?
- Yes. Inter Pharm D.O.O. is the authorised distributor of QuidelOrtho (US) in Montenegro Distribution operates under CInMED wholesale licence number 2050/22/482/2-6492 for medicines and medical devices.
- What does QuidelOrtho make?
- Blood typing and factor determination (Ortho Clinical Diagnostics). Country of origin: US. Manufacturer website: https://www.quidelortho.com/global/en.
- How do I contact Inter Pharm about QuidelOrtho?
- Direct line to Dr pharm. Milos Veljic (Executive Director) — email milos.veljic@interpharm.me, phone +382 20 675-090. Same-business-day reply. The on-site contact form pre-fills with QuidelOrtho context.
Contact us about QuidelOrtho
Direct line to the executive director — Dr pharm. Milos Veljic.